Tenmile’s Post

📣 We’re excited to announce our official rebrand to Xylo Bio! This new identity reflects our growth and focused commitment to advancing neuroplastogens - targeted therapies designed to rewire neural circuits and restore brain function. With our lead candidate XYL-1001 moving toward clinical trials and the addition of industry leaders Elaine Stead, PhD and Margarita Chavez, JD to our Board, we’re entering an exciting phase of innovation in neurotherapeutics. 🚀 Learn more about our evolution in our press release: https://lnkd.in/g3nvVRux 🧪 Joshua Ismin 💊 Sam Banister ⚗️ William Jorgensen Jin Tan Joanna Hare Lachlan Whish Nick Everett Dilara Bahceci Krista Licata Alan Kozikowski Alex Kwan Graham Pechenik Dr. Jianmin Duan Bradley Joblin Anna Goldys Ryan Bethencourt Eric J. Nestler, MD, PhD John Krystal Donald Gehlert, Ph.D. Forest Heims Main Sequence Tenmile Lionheart Ventures Focalpoint Partners Negev Capital Possible Ventures Startmate UNSW Founders Radar Ventures Gabrielle Munzer Chris Hitchen Steve Burnell Mike Lamprecht Emily Casey Shelby Clark Brom Rector, CFA Samantha Tabone Ken Belotsky